Bio-Techne Corporation announced that its President and CEO, Kim Kelderman, will present at the Bank of America Securities 2026 Global Healthcare Conference on May 12, 2026. The presentation will be webcast live and accessible through Bio-Techne's Investor Relations website. Bio-Techne is a global life sciences company with a strong presence in research, diagnostics, and biotechnology, generating over $1.2 billion in net sales in fiscal year 2025. This event provides an opportunity for investors to hear directly from the company's leadership about its strategies and future outlook.
Halper Sadeh LLC is investigating whether shareholders of Arcosa, Bio-Techne, Iridium Communications, and LCI Industries are receiving fair deals in their companies' recent sales. The law firm suspects insiders may gain financial benefits not availab...
Brodsky & Smith LLC has announced investigations into whether the boards of LCI Industries, Iridium Communications, Bio-Techne Corporation, and Arcosa breached their fiduciary duties during recent merger agreements. The investigations focus on whethe...
The global molecular biology enzymes, reagents, and kits market is projected to grow from $27.69 billion in 2025 to $70.85 billion by 2035, at a CAGR of 9.68%. Growth is fueled by rising use of molecular diagnostics, genomics research, and precision ...
Ademi LLP is investigating Bio-Techne's $11.3 billion acquisition by Merck, questioning if public shareholders are receiving a fair price of $73 per share. The law firm alleges possible breaches of fiduciary duty by Bio-Techne's board and highlights ...
